News & Insights
The Visibility Problem in Regulated Storage and What It’s Costing You
The Visibility Problem in Regulated Storage and What It’s Costing You
In regulated life sciences, your reputation is everything. Preclinical specimens, clinical materials, manufacturing...
Key Takeaways from the 2026 SQA Annual Meeting
Key Takeaways from the 2026 SQA Annual Meeting
The Society of Quality Assurance held its 2026 Annual Meeting in National Harbor, Maryland, 13–15 April. With...
UK Extends Clinical Trial Record Retention to 25 Years – Is Your Archive Ready?
UK Extends Clinical Trial Record Retention to 25 Years – Is Your Archive Ready?
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published new guidance that...
What the ToxExpo Floor Told Us: GXP-Storage® at SOT 2026
What the ToxExpo Floor Told Us: GXP-Storage® at SOT 2026
San Diego had 5,000 toxicologists in one room last week. What they told us about storage was more revealing than...
Four Trends Shaping GMP Manufacturing: Takeaways from the ISPE-CaSA Tech Show Contributed by: Chris Smith, Director, Business Development
Four Trends Shaping GMP Manufacturing: Takeaways from the ISPE-CaSA Tech Show Contributed by: Chris Smith, Director, Business Development
Last week, the ISPE-CaSA Tech Show continued its reign as the premier cGMP-focused life science conference in the...
Early-Stage Life Sciences Has More to Lose from Storage Blind Spots Than Big Pharma
Early-Stage Life Sciences Has More to Lose from Storage Blind Spots Than Big Pharma
In early-stage life sciences, fewer materials don’t mean lower risk. They mean less margin for error. When...